(Q122916024)

English

QnAs with Katalin Karikó

scientific article published on 13 December 2021

In more languages

edit

Statements

1 reference

2 October 2023

QnAs with Katalin Karikó (English)

1 reference

2 October 2023

0 references

Prashant Nair

1

1 reference

stated in

Crossref

retrieved

2 October 2023

language of work or name

1 reference

2 October 2023

13 December 2021

1 reference

2 October 2023

Proceedings of the National Academy of Sciences of the United States of America

1 reference

2 October 2023

118

1 reference

2 October 2023

51

1 reference

2 October 2023

e2119757118

0 references

cites work

Liposome mediated DNA-transfer into mammalian cells

0 references

Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA

0 references

Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability

0 references

Foreign nucleic acids as the stimulus to make interferon

0 references

The tangled history of mRNA vaccines

0 references

mRNA-based therapeutics--developing a new class of drugs

0 references

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

0 references

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

0 references

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

0 references

Identifiers

DOI

10.1073/PNAS.2119757118

1 reference

stated in

Crossref

retrieved

2 October 2023

(Q122916024)

QnAs with Katalin Karikó

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)